title: An angiotensin receptor blocker suppresses monocyte chemoattractant protein 1 production from rheumatoid synovial fibroblasts: comment on the article by Sagawa et al.
authors.forename: Noriko
authors.initials: N
authors.lastname: Iikuni
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Okamoto
authors.forename: Mika
authors.initials: M
authors.lastname: Kasahara
authors.forename: Naoyuki
authors.initials: N
authors.lastname: Kamatani
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D018932:Chemokine CCL2 / Q000378:metabolism*; D005347:Fibroblasts / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D013583:Synovial Membrane / Q000166:cytology / Q000187:drug effects*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; C111835:CCL2 protein, human; D018932:Chemokine CCL2